Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page
Your Search Results: 32 Clinics in the ThedaCare health system


The results below represent 44,776 men and women who should have had a colorectal cancer screening. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
THEDACARE BEHAVIORAL HEALTH - MIDWAY

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NEW LONDON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - NORTH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - OSHKOSH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - SHAWANO

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - TCA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE BEHAVIORAL HEALTH - WAUPACA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS - ENDOCRINOLOGY NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS BLACK CREEK

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS CLINTONVILLE
N=1318
77.77 %
View Historical Data
THEDACARE PHYSICIANS DARBOY
N=1633
83.04 %
View Historical Data
THEDACARE PHYSICIANS HILBERT

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE - KNAUS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS INTERNAL MEDICINE APPLETON
N=3096
87.18 %
View Historical Data
THEDACARE PHYSICIANS INTERNAL MEDICINE NEENAH
N=1945
86.74 %
View Historical Data
THEDACARE PHYSICIANS IOLA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS KIMBERLY
N=2017
84.04 %
View Historical Data
THEDACARE PHYSICIANS MANAWA

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS MENASHA
N=3665
82.48 %
View Historical Data
THEDACARE PHYSICIANS NEENAH
N=6469
82.25 %
THEDACARE PHYSICIANS NEW LONDON
N=4190
87.16 %
View Historical Data
THEDACARE PHYSICIANS NORTH
N=6344
83.28 %
View Historical Data
THEDACARE PHYSICIANS OSHKOSH
N=2060
81.55 %
View Historical Data
THEDACARE PHYSICIANS PEDIATRICS APPLETON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS PEDIATRICS NEENAH

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SENIOR CARE SPECIALISTS

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS SHAWANO
N=4951
77.62 %
View Historical Data
THEDACARE PHYSICIANS TIGERTON

The number of patients or providers is too small for
purposes of reliably reporting performance
THEDACARE PHYSICIANS WAUPACA
N=5311
80.78 %
View Historical Data
THEDACARE PHYSICIANS WEST
N=1777
81.71 %
View Historical Data
THEDACARE PHYSICIANS WEYAUWEGA

The number of patients or providers is too small for
purposes of reliably reporting performance

The United States Preventive Services Task Force (USPSTF) strongly recommends that clinicians screen men and women, at age 50 and older for colorectal cancer. The optimal interval for screening depends on the test. Annual fecal occult blood testing (FOBT)/Fecal Immunoassay Test (FIT) offers greater reductions in mortality rates than biennial screening. A 10-year interval has been recommended for colonoscopy, but a 5-year interval is recommended for flexible sigmoidoscopies because of their lower sensitivity. Fecal DNA Screening (Cologuard test) has been added as a new option for screening in 2015 (recommended interval every three years). The USPSTF concluded that the benefits from screening for colorectal cancer substantially outweigh potential harms, and that regardless of screening strategy chosen, it is likely to be cost-effective. In persons identified as being at high-risk by their health care providers, initiating screening at an earlier age is reasonable. It is recommended that all adults speak with their health care providers to determine, on an individual basis, the age at which to begin and end screenings, the best type of screening for individual circumstances, and the frequency of these screenings.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.